Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.


Clinical Trial Description

The overall objective of this study is to determine if infant respiratory morbidities after preterm birth are highly variable due to differential impairment of airway, parenchymal and vascular development that can be characterized as distinct physiologic phenotypes. If the nature and severity of these specific impairments of lung function are strongly associated with increased respiratory morbidities during infancy and that proteomic biomarkers can enhance the physiologic characterization of phenotype and prediction of late respiratory outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03906708
Study type Observational
Source Indiana University
Contact
Status Active, not recruiting
Phase
Start date January 1, 2019
Completion date December 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04209946 - Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants N/A
Recruiting NCT01294852 - Comparison of Two Strategies for Surfactant Prophylaxis in Premature Infants N/A
Recruiting NCT05827250 - Vibroacoustic Study of Lung Development in Newborn Infants
Recruiting NCT06295484 - Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants N/A
Recruiting NCT06367881 - Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS Phase 1
Recruiting NCT06224816 - Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants N/A